subscribe: Posts | Comments

Women wanted for breast cancer drug trial

0 comments

Summary of story from The Yorkshire Post, October 12, 2011

Women at higher risk of developing breast cancer in Yorkshire have been asked by charity group Cancer Research UK to take part in a new world-wide drug trial to look at preventing the disease.

Eleven women a day are diagnosed with breast cancer in the Yorkshire region.

Cancer Research UK are appealing to higher risk women – those who have a family history of breast cancer or other risk factors, such as certain types of non-cancerous breast lumps – to participate in their IBIS-2 study.

The study will be based on findings that suggest early results using the drug anastrozole could help prevent as many as two thirds of breast cancers in high-risk patients.

The trial is being carried out at a number of hospitals in Yorkshire and is open to high risk post-menopausal women aged between 40-70 who are not on hormone replacement therapy (HRT).

Professor Jack Cuzick, of the Wolfson Institute of Preventive Medicine in London, principal investigator in the trial said: “The good news is that early results show the drug could potentially prevent up to 65 per cent of breast cancers in women at high risk of the disease so it could be the next big step forward in preventing breast cancer for future generations.”

Women from Yorkshire – and elsewhere – who would like to find out if they are eligible to take part in the study, can go to www.ibis-trials.org

Or ring the research team on 0800 111 4134 or Cancer Research UK’s cancer information nurses on 0808 800 4040

Leave a Reply

Your email address will not be published. Required fields are marked *